Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Special Report: Summary of the Eighth Workshop of the Worldwide Network for Blood and Marrow Transplantation on the Status and Issues Related to Hematopoietic Stem Cell Transplantation in Near-East Countries, Held in Pakistan From September 22 to 23, 2022 Publisher Pubmed



Greinix HT1 ; Iftikhar R2 ; Chaudhry QUN2 ; Ahmed P3 ; Alkhabori M4 ; Gaziev J5 ; Hamidieh AA6 ; Hashmi S7, 8 ; Khan M9 ; Poudyal BS10 ; Shaheen M11 ; Rasheed W12 ; Galeano S13 ; Kodera Y14 Show All Authors
Authors
  1. Greinix HT1
  2. Iftikhar R2
  3. Chaudhry QUN2
  4. Ahmed P3
  5. Alkhabori M4
  6. Gaziev J5
  7. Hamidieh AA6
  8. Hashmi S7, 8
  9. Khan M9
  10. Poudyal BS10
  11. Shaheen M11
  12. Rasheed W12
  13. Galeano S13
  14. Kodera Y14
  15. Niederwieser D15
  16. Ahmed SO16
  17. Atsuta Y17, 18
  18. Baldomero H19
  19. Frutos C20
  20. Iida M21
  21. Okamoto S22
  22. Rondelli D23
  23. Schwartz J24
  24. Seber A25
  25. Weisdorf D26
  26. Worel N27
  27. Chatzixiros E28
  28. Koh MB29
  29. Aljurf M30

Source: Hematology/oncology and stem cell therapy Published:2024


Abstract

The eighth workshop of the Worldwide Network for Blood and Marrow Transplantation (WBMT) was held in Islamabad, Pakistan, from September 22 to 23, 2022, aiming to foster hematopoietic stem cell transplant (HSCT) activity in the World Health Organization (WHO) Eastern Mediterranean Region (EMRO). Participating countries, including Pakistan, Oman, Iran, and Saudi Arabia, reported increased HSCT in the last few years, whereas others from the EMRO and beyond, including Qatar, United Arab Emirates, Nepal, and Bangladesh, started HSCT recently and have developed HSCT programs with excellent results. During educational sessions and open dialog, participating teams and international experts from the WBMT shared their experience and discussed minimum essential requirements for establishing and expanding HSCT in emerging countries, indications for HSCT training and dissemination of knowledge, stem cell donor selection and safety, quality assurance in transplant centers, and the value and importance of transplant outcome databases. International support, collaboration, and local engagement, including government participation and WHO assistance, are valuable in increasing HSCT access worldwide. Copyright © 2024 Hematology/Oncology and Stem Cell Therapy.
Other Related Docs
4. Hsct at a Glance, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
18. Medical Oncology, History and Its Future in Iran, Archives of Iranian Medicine (2015)